Optometrists in Taos, NM Accepting Medicare
7 Optometrists found. Showing 1 - 7
 Dr. Robert D Ratzlaff, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1353 Paseo Del Pueblo Sur, Suite C, Taos, NM 87571 Phone: 575-758-3215 Fax: 575-751-9280 |
 Dr. Jane Ellen Compton, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 710 F South Santa Fe Rd, Taos, NM 87571 Phone: 575-758-2205 Fax: 575-751-7102 |
 Robert Ratzlaff Od Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1128-a Paseo Del Pueblo Sur, 7653 Ndcbu, Taos, NM 87571 Phone: 505-758-3215 Fax: 505-751-9280 |
Realeyes Inc Optometrist Medicare: Medicare Enrolled Practice Location: 1353 Paseo Del Pueblo Sur, Suite C, Taos, NM 87571 Phone: 575-758-3215 Fax: 575-751-9280 |
Jane Compton Od Optometrist Medicare: Medicare Enrolled Practice Location: 710 Paseo Del Pueblo Sur Ste F, Taos, NM 87571 Phone: 575-758-2205 Fax: 575-751-7102 |
Eye Associates Of New Mexcio Optometrist Medicare: Medicare Enrolled Practice Location: 1399 Weimer Rd, Suite 300, Taos, NM 87571 Phone: 505-758-0621 Fax: 505-758-0622 |
Jane Compton O.d. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 710 S Santa Fe Rd Ste F, Taos, NM 87571 Phone: 575-758-2205 Fax: 575-751-7102 |
News Archive
Michigan Gubernatorial candidate DeVos 'thrilled' if state could enforce abortion ban
Michigan gubernatorial candidate Dick DeVos (R) on Thursday during a radio interview said he would be "thrilled" if Michigan were to reinstate a state law that banned abortion except to save a pregnant woman's life "[a]s soon as Roe v. Wade" - the 1973 U.S. Supreme Court case that effectively barred state abortion bans - "is overturned, which I think we all pray it will be".
Vitro Diagnostics completes private placement of common stock and warrants to raise cash infusion
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the completion of a private placement of its common stock and warrants representing an initial investment of $87,500, with an additional $87,500 should the warrants be exercised, by a group of private investors who previously purchased the Company's stock at a 36% lower price, through a prior private placement. Please see the associated Form 8-K for additional details regarding this transaction.
Telethermographic device is not approved for screening breast cancer
The U.S. Food and Drug Administration today warned women not to substitute breast thermography for mammography to screen for breast cancer.
Combination of PD-991 and letrozole improves survival in patients with HER2- breast cancer
Pfizer Inc. today announced randomized Phase 2 data that showed PD-0332991 (PD-991) in combination with letrozole significantly extended progression free survival (PFS) compared with letrozole alone in post-menopausal patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer.
› Verified 4 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Occupational Therapists
Podiatrists